D2C = Dublin | CMC | CDMO Pharma companies - from Start-Ups to Big Pharma - meet CMC Experts and CDMOs. The format follows our previous events. Small size (50 people), highly quality speakers and good networking.
How we navigated compounding process changes, non-comparable proposals, and hidden CDMO risks.
In just four weeks we provided a strong analysis of CMC elements, embedded in financial, legal and operational issues.
We have made our Pharmagro Portfolio ManagementTool P2MT easier to use! In the Evaluation Section we have added templates. Use these to get started quickly on your evaluations.
See how Pharmagro could help your team structure the uncertainty, explore alternative scenarios and move toward a clearer decision.
